MassDevice

Abbott: Study shows neuromod systems greatly reduce pain-related healthcare visits

Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.
Pharmabiz

Five-year data shows Abbott neuromodulation systems reduce healthcare visits related to pain and deliver sustained relief

Abbott Park, Illinois Tuesday, January 27, 2026, 13:00 Hrs [IST] ...
Medscape

FDA OKs Full-Body MRI for Neurostimulation System for Lower Limb Pain

The US Food and Drug Administration (FDA) has approved expanded MRI labeling for Abbott's Proclaim dorsal root ganglion (DRG) neurostimulator system in patients with complex regional pain syndrome ...
Medscape

FDA Clears 'Recharge-Free' Neurostimulation Device for Chronic Pain

The US Food and Drug Administration (FDA) has approved Abbott Laboratories' Proclaim XR neurostimulation system for chronic pain patients. The device has a battery life of up to 10 years, the company ...
Seeking Alpha

Abbott Receives FDA Approval for Its Spinal Cord Stimulation Systems to Treat Chronic Back Pain in People Who Have Limited Surgical Options

ABBOTT PARK, Ill., May 16, 2023 /PRNewswire/ -- Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of ...

Basivertebral nerve ablation provides early, sustained chronic low back pain relief

Chronic low back pain significantly affects quality of life for millions of people worldwide. Back pain makes it difficult to ...
UC San Francisco

Is the Holy Grail for Treating Chronic Back Pain Within Reach?

Whether it’s a dull, underlying ache in your spine or a piercing stab, chronic back pain affects roughly 1 in 4 Americans. UC San Francisco’s Prasad Shirvalkar, MD, Ph.D, neurologist and pain medicine ...